Emtricitabine / Tenofovir Disoproxil Fumarate

Common brands: Truvada, Viread, Norvir, Biktarvy, Descovy

Top reporter: Gilead Sciences, Inc

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 3A Inhibitor [EPC]Protease Inhibitor [EPC]Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
45,135
Total Reports
19,105
Serious Reports
1,803
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.99%)

Patient Demographics

Male
29,319
Female
12,186

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Emtricitabine / Tenofovir Disoproxil Fumarate.

# Reaction Reports % of Total
1 BONE DENSITY DECREASED 16,540
11.7%
2 CHRONIC KIDNEY DISEASE 10,325
7.3%
3 OSTEONECROSIS 9,133
6.4%
4 BONE LOSS 9,075
6.4%
5 RENAL FAILURE 8,991
6.3%
6 MULTIPLE FRACTURES 8,157
5.7%
7 TOOTH LOSS 8,107
5.7%
8 RENAL INJURY 8,004
5.6%
9 OSTEOPOROSIS 7,264
5.1%
10 SKELETAL INJURY 7,173
5.1%
11 PAIN 6,583
4.6%
12 EMOTIONAL DISTRESS 6,349
4.5%
13 ANXIETY 5,939
4.2%
14 ANHEDONIA 5,605
3.9%
15 OSTEOPENIA 3,920
2.8%
16 ACUTE KIDNEY INJURY 2,220
1.6%
17 RENAL IMPAIRMENT 2,183
1.5%
18 BLOOD CREATININE INCREASED 2,091
1.5%
19 TOOTH INJURY 2,087
1.5%
20 ECONOMIC PROBLEM 1,943
1.4%
21 FRACTURE 1,294
0.9%
22 FOETAL EXPOSURE DURING PREGNANCY 1,158
0.8%
23 NEPHROPATHY 1,107
0.8%
24 VITAMIN D DEFICIENCY 1,075
0.8%
25 BONE DENSITY ABNORMAL 1,038
0.7%
26 DEPRESSION 1,037
0.7%
27 FATIGUE 918
0.6%
28 DIARRHOEA 882
0.6%
29 OFF LABEL USE 860
0.6%
30 NAUSEA 843
0.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.